Rapid Antigen Test Listed by WHO for Emergency Use for Detecting COVID-19

In response to SARS-CoV-2/COVID-19, Copenhagen Medical A/S recently became a sales representative for SD Biosensor from South Korea re. their COVID-19 Rapid Test Kits in the Kingdom of Denmark, Sweden and Iceland.

SD Biosensor is specialised in in-vitro diagnostics and established with the objective of contributing to improving the quality of life through fast and accurate diagnosis of disease.

On 22 September 2020, WHO listed SD Bionsensor’s Antigen (Ag) Test for Emergency Use for detecting SARS-CoV-2 to help curb the spread of SARS-CoV-2/COVID-19 among people worldwide.

SD Biosensor’s Ag Test tests levels of nucleoprotein antigens to SARS-CoV-2/COVID-19 present in human nasopharynx, i.e. it tests whether a person is infected with SARS-CoV-2/COVID-19 here and now.

The Ag Test has a sensitivity level of 96.52% and a specificity level of 99.68%.

The Ag Test is done in approx. 18-20 minutes on site by means of a nasal swab.

Copenhagen Medical A/S currently has a large batch of validated test kits on stock in Copenhagen and is thus able to ship out test kits on a short notice to any destination worldwide, i.e. from day to day.

Copenhagen Medical A/S can also arrange for test of staff in Denmark by means of certified nurses and/or medical practitioners.

Via the Danish online pharmacy, www.apopro.dk, Copenhagen Medical A/S sells and distributes SD Bionsensor’s rapid COVID-19 test kits.

For more information and pricing contact Carsten Balleby,  COO, at caba@cphgroup.com.